Vaccines against persistent DNA virus infections.
Persistent viruses present some particular problems for vaccine design. As for acute non-persistent viruses, the prime goal of a vaccine should be to prevent primary infection. Vaccines might also be used to modify the course of established persistent virus infections - so-called postinfective immunisation. This chapter deals with selected persistent DNA viruses, in particular the human herpes viruses.
Wills
M R
MR
Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Carmichael
A J
AJ
Sissons
J G P
JG
D002644:Chickenpox / Q000517:prevention & control; D003586:Cytomegalovirus Infections / Q000517:prevention & control; D004266:DNA Virus Infections / Q000517:prevention & control*; D020031:Epstein-Barr Virus Infections / Q000517:prevention & control; D006561:Herpes Simplex / Q000517:prevention & control; D006801:Humans; D014765:Viral Vaccines
D014765:Viral Vaccines